On the heels of a tough week for software stocks, Palantir Technologies Inc. came in just above expectations with its latest quarterly revenue performance while raising its outlook on an Read more
Tag: Analysts' Comments/Recommendations
Warner Bros. Discovery’s ‘tough juggling act’ sends stock dropping toward 13-year low
Shares of Warner Bros. Discovery Inc. were plunging Friday toward closing levels not seen since May 2009 as the media giant’s latest earnings report highlighted challenges prevalent across the industry Read more
DraftKings stock heads for worst day on record as patience with losses ‘remains thin’
Shares of DraftKings Inc. were headed for their worst daily performance on record Friday after the sports-betting company topped revenue expectations but appeared to spook investors with its discussion of Read more
Hershey’s Q3 results ‘cleared a high bar’ but outlook conservative, says UBS analyst
Hershey Co.’s third-quarter results surpassed investors’ lofty expectations but the company’s raised outlook is conservative, according to UBS analyst Cody Ross. The maker of Reese’s Peanut Butter Cups, Kit Kats, Read more
Twilio’s stock tumbles as quarterly loss, outlook spook investors
Shares of Twilio Inc. tumbled as much as 17% in extended trading Thursday after the customer-engagement technology company reported mixed fiscal third-quarter results that met Wall Street analysts’ forecasts, but a Read more
Apple’s AR glasses could be pushed back to 2025 or 2026 amid ‘design issues,’ says analyst
Apple Inc.’s rumored augmented-reality glasses may not appear until 2025 or 2026, according to Jeff Pu, an analyst at Haitong International Tech Research. The tech giant’s augmented- and virtual-reality moves Read more
Lumen stock falls after dividend is eliminated, but is there a silver lining?
Lumen Technologies Inc. shares were falling sharply in Thursday trading after the telecommunications company announced it was eliminating its dividend and selling another business, moves that have prompted tough questions Read more
Opinion: Investors in drug stocks should ignore dubious valuations based on rigged methodologies
The investment firm Morningstar has announced that it will now pick drug stocks based upon each company’s vulnerability to poor reviews of their prices by the Institute for Clinical and Read more
Qualcomm stock drops more than 5% after poor outlook, months-long chip glut
Qualcomm Inc. shares fell in the extended session Wednesday following the chip maker’s poor outlook, and estimates of about two months or more of inventory it needs to clear in Read more
Midterm elections: Senate control may not be determined until December. Here’s why.
The midterm elections are now less than a week away, but it might take until December to find out if Democrats have kept their tenuous grip on the U.S. Senate. Read more